{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:08:37Z","timestamp":1773148117982,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":2808,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.breast.2011.09.001","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T11:29:47Z","timestamp":1316172587000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"S\u00f2nia","family":"Servitja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Nogu\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Prieto-Alhambra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Garrig\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"de Ramon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"D\u00edez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Albanell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignasi","family":"Tusquets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2011.09.001_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1477-7525-2-41","article-title":"The ECOS-16 questionnaire for the evaluation of health related quality of life in post-menopausal women with osteoporosis","volume":"2","author":"Badia","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.breast.2011.09.001_bib3","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2011.09.001_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1530\/eje.0.1300038","article-title":"Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition\u2013an analysis of FSH, oestradiol and inhibin","volume":"130","author":"Burger","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.breast.2011.09.001_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2011.09.001_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib7","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1200\/JCO.2007.15.7123","article-title":"Tamoxifen use and osteoporotic fracture risk: a population-based analysis","volume":"26","author":"Cooke","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib8","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A\u00a0randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2011.09.001_bib9","first-page":"2767","article-title":"Aromatase inhibitors and arthralgia","volume":"19","author":"Donnellan","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.breast.2011.09.001_bib11","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1200\/JCO.2008.20.0725","article-title":"Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer","volume":"27","author":"Goodwin","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib12","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A\u00a0randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2011.09.001_bib13","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/annonc\/mdn164","article-title":"Practical guidance for the management of aromatase inhibitor-associated bone loss","volume":"19","author":"Hadji","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mdn762","article-title":"Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy","volume":"20","author":"Hadji","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.breast.2009.03.003","article-title":"The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial","volume":"18","author":"Hadji","year":"2009","journal-title":"Breast"},{"key":"10.1016\/j.breast.2011.09.001_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol","volume":"77","author":"Heaney","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.breast.2011.09.001_bib17","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2004-2364","article-title":"Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy","volume":"90","author":"Holick","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2011.09.001_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2011.09.001_bib19","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2011.09.001_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2011.09.001_bib21","series-title":"Clinician\u2019s Guide to Prevention and treatment of osteoporosis","year":"2009"},{"key":"10.1016\/j.breast.2011.09.001_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00198-007-0501-2","article-title":"Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study","volume":"19","author":"Nieves","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.breast.2011.09.001_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.maturitas.2010.03.012","article-title":"Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer","volume":"66","author":"Nogues","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.breast.2011.09.001_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0212-6567(04)79409-3","article-title":"Predicci\u00f3n de la ingesta total de calcio a trav\u00e9s del consumo de l\u00e1cteos en la poblaci\u00f3n adulta de Espa\u00f1a. Estudio INDICAD 2001","volume":"33","author":"Orozco","year":"2004","journal-title":"Aten Primaria"},{"key":"10.1016\/j.breast.2011.09.001_bib25","article-title":"Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study","author":"Prieto-Alhambra","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2011.09.001_bib26","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/annonc\/mdp033","article-title":"Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial","volume":"20","author":"Rabaglio","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.maturitas.2009.07.008","article-title":"Prevention of osteoporosis after breast cancer","volume":"64","author":"Reid","year":"2009","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.breast.2011.09.001_bib28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ctrv.2008.03.007","article-title":"Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group","volume":"34","author":"Reid","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.breast.2011.09.001_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/028418698430007","article-title":"Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer","volume":"37","author":"Resch","year":"1998","journal-title":"Acta Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib30","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1200\/JCO.2005.03.903","article-title":"Aromatase inhibitors and bone loss: risks in perspective","volume":"23","author":"Shapiro","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","article-title":"Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society","volume":"17","author":"Silverman","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.breast.2011.09.001_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.maturitas.2004.02.018","article-title":"Changes in bone mineral density during and after 3 years\u2019 use of tamoxifen or toremifene","volume":"48","author":"Tiitinen","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.breast.2011.09.001_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2008.04.005","article-title":"Start strong or switch? Adjuvant endocrine strategies for postmenopausal women with hormone-sensitive breast cancer","volume":"63","author":"Tusquets","year":"2009","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.breast.2011.09.001_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bone.2007.11.002","article-title":"Vitamin D deficiency as a risk factor for osteoporotic fractures","volume":"42","author":"van Schoor","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.breast.2011.09.001_bib35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/gme.0b013e3181bc1c84","article-title":"Altering the propensity for density: the benefits and risks of selective estrogen receptor modulators","volume":"16","author":"Vogel","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.breast.2011.09.001_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0169-6009(08)80220-6","article-title":"Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women","volume":"22","author":"Ward","year":"1993","journal-title":"Bone Miner"},{"key":"10.1016\/j.breast.2011.09.001_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","article-title":"American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004","volume":"23","author":"Winer","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2011.09.001_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/MO:21:2:117","article-title":"Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer","volume":"21","author":"Zidan","year":"2004","journal-title":"Med Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977611003250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977611003250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:28:48Z","timestamp":1760776128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977611003250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0960977611003250"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2011.09.001","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2011.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}